1. Auryxia [Prescribing Information]. New York, NY: Keryx Biopharmaceuticals, Inc.; July 2015.
2. Lewis JB, Sika M, Koury MJ, et al. Ferric citrate controls phosphorus and delivers iron in patients on dialysis. J Am Soc Nephrol. 2014;ePublished July 24, 2014.
3. Dwyer JP, Sika M, Schulman G, et al. Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial. Am J Kidney Dis. 2013;61(5):759-766.
4. MicromedexR Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. January 20, 2016.
5. Clinical Pharmacology Web site. Available at: http://cpip.gsm.com/. Accessed January 20, 2016.
6. Auryxia. American Hospital Formulary Service Drug Information. Available at: http://www.medicinescomplete.com/mc/ahfs/current/. Accessed January 20, 2016.
7. Renvela. [Prescribing Information]. Cambridge, MA: Genzyme Corporation; January 2015.
8. Renagel. [Prescribing Information]. Cambridge, MA: Genzyme Corporation; January 2015.
9. Fosrenal. [Prescribing Information]. Wayne, PA: Shire US Inc.; September 2014.
10. Velphoro. [Prescribing Information]. Waltham, MA: Fresenius Medical Care North America; September 2014.